Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0XH1F
|
||||
| Former ID |
DNC010407
|
||||
| Drug Name |
4-fluorophenyl 4-butoxybenzylcarbamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula |
C18H20FNO3
|
||||
| Canonical SMILES |
CCCCOC1=CC=C(C=C1)CNC(=O)OC2=CC=C(C=C2)F
|
||||
| InChI |
1S/C18H20FNO3/c1-2-3-12-22-16-8-4-14(5-9-16)13-20-18(21)23-17-10-6-15(19)7-11-17/h4-11H,2-3,12-13H2,1H3,(H,20,21)
|
||||
| InChIKey |
BVPXJSVMJYBIRX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.